OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management
Mandeep Singh, Bhrigu Kumar Das, Sandeep Choudhary, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 106, pp. 991-1002
Closed Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies
Erica Vetrano, Luca Rinaldi, Andrea Mormone, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 468-468
Open Access | Times Cited: 41

Epigenetic Perspectives and Their Prognostic Value in Early Recurrence After Hepatocellular Carcinoma Resection
Chang-Yi Lu, Ching‐Pin Lin, Hsiang‐Lin Lee, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 769-769
Open Access | Times Cited: 1

Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease
Diwakar Suresh, Akshatha N. Srinivas, Divya P. Kumar
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 124

Effects of Isorhamnetin on Diabetes and Its Associated Complications: A Review of In Vitro and In Vivo Studies and a Post Hoc Transcriptome Analysis of Involved Molecular Pathways
Feten Zar Kalai, Mondher Boulaaba, Farhana Ferdousi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 704-704
Open Access | Times Cited: 42

Does maternal low-dose cadmium exposure increase the risk of offspring to develop metabolic syndrome and/or type 2 diabetes?
Saman Saedi, Sara E. Watson, Jamie L. Young, et al.
Life Sciences (2023) Vol. 315, pp. 121385-121385
Open Access | Times Cited: 22

The vital role of ATP citrate lyase in chronic diseases
Amrita Devi Khwairakpam, Kishore Banik, Sosmitha Girisa, et al.
Journal of Molecular Medicine (2019) Vol. 98, Iss. 1, pp. 71-95
Closed Access | Times Cited: 63

BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway
Jiannan Qiu, Shaopeng Zhang, Peng Wang, et al.
Cancer Medicine (2020) Vol. 9, Iss. 21, pp. 8159-8172
Open Access | Times Cited: 57

Nuclear translocation of metabolic enzyme PKM2 participates in high glucose-promoted HCC metastasis by strengthening immunosuppressive environment
Jiali Qian, Chuxin Huang, Mimi Wang, et al.
Redox Biology (2024) Vol. 71, pp. 103103-103103
Open Access | Times Cited: 6

The role and mechanism of selenium in the prevention and progression of hepatocellular carcinoma
Qing Luo, Xiaofang Bai, Xiaojiao Li, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access

Key genes associated with diabetes mellitus and hepatocellular carcinoma
Gao‐Min Liu, Huadong Zeng, Caiyun Zhang, et al.
Pathology - Research and Practice (2019) Vol. 215, Iss. 11, pp. 152510-152510
Closed Access | Times Cited: 50

Type 2 Diabetes Prevention Diet and Hepatocellular Carcinoma Risk in US Men and Women
Xiao Luo, Jing Sui, Wanshui Yang, et al.
The American Journal of Gastroenterology (2019) Vol. 114, Iss. 12, pp. 1870-1877
Open Access | Times Cited: 43

Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges
Li Shen, Antonio Saviano, Derek J. Erstad, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3817-3817
Open Access | Times Cited: 37

Association between Liver Cirrhosis and Diabetes Mellitus: A Review on Hepatic Outcomes
Laura Coman, Oana Andreia Coman, Ioana Anca Bădărău, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 2, pp. 262-262
Open Access | Times Cited: 31

Metformin modulate immune fitness in hepatocellular carcinoma: Molecular and cellular approach
Eslam E. Abd El-Fattah, Amr Y. Zakaria
International Immunopharmacology (2022) Vol. 109, pp. 108889-108889
Closed Access | Times Cited: 18

Diabetes mellitus and endometrial carcinoma: Risk factors and etiological links
Ya Wang, Xinling Zeng, Jie Tan, et al.
Medicine (2022) Vol. 101, Iss. 34, pp. e30299-e30299
Open Access | Times Cited: 16

Long Non-Coding RNA LINC01572 Promotes Hepatocellular Carcinoma Progression via Sponging miR-195-5p to Enhance PFKFB4-Mediated Glycolysis and PI3K/AKT Activation
Shihui Lai, Zhipeng Quan, Yuesong Hao, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 21

Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease
Pai‐Chi Teng, Daniel Q. Huang, Ting‐Yi Lin, et al.
Gut and Liver (2022) Vol. 17, Iss. 1, pp. 24-33
Open Access | Times Cited: 15

Excess Body Weight and the Risk of Liver Cancer: Systematic Review and a Meta-Analysis of Cohort Studies
Chao Yang, Yifei Lü, Hui Xia, et al.
Nutrition and Cancer (2019) Vol. 72, Iss. 7, pp. 1085-1097
Closed Access | Times Cited: 23

Gestational Cd Exposure in the CD-1 Mouse Induces Sex-Specific Hepatic Insulin Insensitivity, Obesity, and Metabolic Syndrome in Adult Female Offspring
Thomas W. Jackson, Garret L. Ryherd, Chris M. Scheibly, et al.
Toxicological Sciences (2020) Vol. 178, Iss. 2, pp. 264-280
Open Access | Times Cited: 23

Glycaemic control is a modifiable risk factor for hepatocellular carcinoma and liver‐related mortality in patients with diabetes
Xianhua Mao, Ka Shing Cheung, Jing‐Tong Tan, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 10, pp. 1398-1408
Open Access | Times Cited: 2

Associations between diabetes mellitus and the risk of hepatocellular carcinoma in Asian individuals with hepatitis B and C infection: systematic review and a meta-analysis of cohort studies
Chao Yang, Min Wan, Yifei Lü, et al.
European Journal of Cancer Prevention (2022) Vol. 31, Iss. 2, pp. 107-116
Closed Access | Times Cited: 10

The 20 years transition of clinical characteristics and metabolic risk factors in primary liver cancer patients from China
Yezhou Ding, Mingyang Feng, Di Ma, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5

Daytime napping, nighttime sleeping duration, and risk of hepatocellular carcinoma and liver disease-related mortality
Lu Long, Longgang Zhao, Jessica L. Petrick, et al.
JHEP Reports (2023) Vol. 5, Iss. 10, pp. 100819-100819
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top